Transatlantic Course of ESR and RSNA (Radiological Society of North America): Advances in Prostate Cancer Imaging and Therapy
TC 927 - Population to precision oncology in prostate cancer
Lectures
1
Chairpersons' introduction
04:00Katarzyna J. (Kasia) Macura, Baltimore / US, Ivo Gerardus Schoots, Rotterdam / NL
2
MR imaging in screening/organised testing in Europe
14:00Ivo Gerardus Schoots, Rotterdam / NL
3
Novel multimodality imaging biomarkers
14:00Fiona M. Fennessy, Boston / US
4
Image-guided therapies for prostate cancer
14:00Katarzyna J. (Kasia) Macura, Baltimore / US
5
Panel discussion
14:00Panel discussion
The attendees will learn about the basis for the European screening recommendations from the European Union's Beating Cancer Plan and discuss the challenges and controversies of prostate cancer screening vs early detection, based on guidelines (EAU/AUA/NCCN). The session will review the role of imaging biomarkers in the detection and characterisation of prostate cancer, guidance of personalised treatment planning, prediction and assessment of response to therapy, and detection of disease recurrence. Furthermore, it will explore the emerging image-guided focal therapies as methods for personalised treatment of prostate cancer based on risk criteria and optimisation of oncologic and life quality outcomes.
4 min
Chairpersons' introduction
Katarzyna J. (Kasia) Macura, Baltimore / United States
Ivo Gerardus Schoots, Rotterdam / Netherlands
Ivo Gerardus Schoots, Rotterdam / Netherlands
14 min
MR imaging in screening/organised testing in Europe
Ivo Gerardus Schoots, Rotterdam / Netherlands
14 min
Novel multimodality imaging biomarkers
Fiona M. Fennessy, Boston / United States
14 min
Image-guided therapies for prostate cancer
Katarzyna J. (Kasia) Macura, Baltimore / United States
14 min
Panel discussion